Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Sanders

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Journal of Translational Medicine|December 21, 2018
Towards the use of diffuse reflectance spectroscopy for real-time in vivo detection of breast cancer during surgeryLisanne L de Boer, Torre M Bydlon, Frederieke van Duijnhoven, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2020
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapyMartijn van der Heijden, Paul B M Essers, Caroline V M Verhagen, et al.
International Journal of Surgical Pathology|April 25, 2022
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory AnalysisLaura S Mertens, Francesco Claps, Roman Mayr, et al.
Gynecologic Oncology|May 26, 2023
WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II studyAlaa Embaby, Joachim Kutzera, Jill J Geenen, et al.
Cancer Immunology Research|June 5, 2014
Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapyEsther P M Tjin, Gabrielle Krebbers, Kimberley J Meijlink, et al.
Insights Into Imaging|July 21, 2023
Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastasesZuhir Bodalal, Nino Bogveradze, Leon C Ter Beek, et al.
Journal of Biomedical Optics|February 1, 2019
Hyperspectral imaging for tissue classification, a way toward smart laparoscopic colorectal surgeryElisabeth J M Baltussen, Esther N D Kok, Susan G Brouwer de Koning, et al.
Nature Medicine|July 9, 2021
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancerPaula Voabil, Marjolein de Bruijn, Lisanne M Roelofsen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancerSjoerd H den Uil, Meike de Wit, Robbert J C Slebos, et al.
The American Journal of Surgical Pathology|June 18, 2019
Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCISLindy L Visser, Lotte E Elshof, Koen Van de Vijver, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Journal of Translational Medicine|December 21, 2018
Towards the use of diffuse reflectance spectroscopy for real-time in vivo detection of breast cancer during surgeryLisanne L de Boer, Torre M Bydlon, Frederieke van Duijnhoven, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2020
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapyMartijn van der Heijden, Paul B M Essers, Caroline V M Verhagen, et al.
International Journal of Surgical Pathology|April 25, 2022
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory AnalysisLaura S Mertens, Francesco Claps, Roman Mayr, et al.
Gynecologic Oncology|May 26, 2023
WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II studyAlaa Embaby, Joachim Kutzera, Jill J Geenen, et al.
Cancer Immunology Research|June 5, 2014
Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapyEsther P M Tjin, Gabrielle Krebbers, Kimberley J Meijlink, et al.
Insights Into Imaging|July 21, 2023
Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastasesZuhir Bodalal, Nino Bogveradze, Leon C Ter Beek, et al.
Journal of Biomedical Optics|February 1, 2019
Hyperspectral imaging for tissue classification, a way toward smart laparoscopic colorectal surgeryElisabeth J M Baltussen, Esther N D Kok, Susan G Brouwer de Koning, et al.
Nature Medicine|July 9, 2021
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancerPaula Voabil, Marjolein de Bruijn, Lisanne M Roelofsen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancerSjoerd H den Uil, Meike de Wit, Robbert J C Slebos, et al.
The American Journal of Surgical Pathology|June 18, 2019
Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCISLindy L Visser, Lotte E Elshof, Koen Van de Vijver, et al.
Pageof 9